Thalys(SH:603716) Sou Hu Cai Jing·2025-08-22 06:25Core Viewpoint - The stock of Selys Medical experienced a significant increase of 10.02%, reaching a price of 31.52 yuan per share, with a trading volume of 1.519 billion yuan and a turnover rate of 26.46%, resulting in a total market capitalization of 6.021 billion yuan [1] Company Overview - Selys Medical Technology Group Co., Ltd. is located at 1310 Jinshan Avenue, Dongxihu District, Wuhan, and primarily operates in the field of medical intensive operation management services [1] - The company has established partnerships with well-known IVD suppliers both domestically and internationally, providing comprehensive supply chain services for in vitro diagnostic products [1] - Selys Medical is advancing its information technology capabilities to support the construction of an intensive operation service platform, with deep investments in supply chain information technology, blockchain, and the Internet of Things [1] Financial Performance - As of March 31, the number of shareholders for Selys Medical was 46,600, with an average of 4,099 circulating shares per person [1] - For the first quarter of 2025, Selys Medical reported an operating revenue of 287 million yuan, a year-on-year decrease of 40.75% [1] - The net profit attributable to shareholders was -14.32 million yuan, reflecting a year-on-year decline of 553.66% [1]